Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

6.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.9K
Mismatch Repair01:36

Mismatch Repair

44.8K
Overview
44.8K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.2K
3.2K
Mutations01:39

Mutations

96.0K
Overview
96.0K
Mutations01:35

Mutations

45.4K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accurate detection of subclonal variants in paired diagnosis-relapse acute myeloid leukemia samples by next generation Duplex Sequencing.

Leukemia research·2022
Same author

PolyG-DS: An ultrasensitive polyguanine tract-profiling method to detect clonal expansions and trace cell lineage.

Proceedings of the National Academy of Sciences of the United States of America·2021
Same author

Rare Mutations in Cancer Drug Resistance and Implications for Therapy.

Clinical pharmacology and therapeutics·2020
Same author

Extensive subclonal mutational diversity in human colorectal cancer and its significance.

Proceedings of the National Academy of Sciences of the United States of America·2019
Same author

A high-resolution landscape of mutations in the <i>BCL6</i> super-enhancer in normal human B cells.

Proceedings of the National Academy of Sciences of the United States of America·2019
Same author

Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan.

Cell reports·2019

Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.3K

Human Cancers Express a Mutator Phenotype: Hypothesis, Origin, and Consequences.

Lawrence A Loeb1

  • 1Department of Pathology, University of Washington School of Medicine, Seattle, Washington. Department of Biochemistry, University of Washington School of Medicine, Seattle, Washington. laloeb@uw.edu.

Cancer Research
|May 20, 2016
PubMed
Summary
This summary is machine-generated.

The mutator phenotype hypothesis suggests that reduced DNA replication accuracy drives tumor progression and heterogeneity. This genomic instability can accelerate cancer development and resistance to therapies.

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.1K
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.9K

Related Experiment Videos

Last Updated: Mar 21, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.3K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

5.1K
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.9K

Area of Science:

  • Genetics
  • Cancer Biology
  • Molecular Oncology

Background:

  • The mutator phenotype hypothesis, proposed over 40 years ago, addresses the complexity of DNA replication.
  • Accurate replication of the human genome (6 billion bases) involves multiple enzymatic steps.
  • Genomic instability during tumor progression may explain cancer cell heterogeneity and rapid development of therapy resistance.

Purpose of the Study:

  • To review the mutator phenotype hypothesis in the context of cancer progression.
  • To discuss the implications of reduced DNA replication fidelity in cancer.
  • To highlight the link between mutator phenotypes and clinical challenges in oncology.

Main Methods:

  • Review of foundational and contemporary research on the mutator phenotype.
  • Analysis of the enzymatic processes involved in human genome replication.
  • Discussion of the consequences of replication errors in tumor development.

Main Results:

  • Reduced DNA replication accuracy is a potential driver of tumor heterogeneity.
  • Genomic instability contributes to the rapid evolution of cancer cells.
  • Mutator phenotypes can lead to faster development of drug resistance.

Conclusions:

  • The mutator phenotype hypothesis remains relevant for understanding cancer progression.
  • Genomic instability is a key factor in the complexity and treatment challenges of cancer.
  • Further research into DNA repair and replication fidelity is crucial for cancer therapy.